细胞外容积分数用于透明细胞肾细胞癌分级的评估:初步结果与组织病理学发现
这项单中心前瞻性研究纳入27例经病理诊断为透明细胞肾细胞癌的患者,于2017年1月至2018年6月间在1.5 T下行腹部MRI,采用改良Look-Locker反转恢复序列测量T1值并计算细胞外容积分数(ECV),以组织病理学ISUP核分级为参考标准。结果显示,增强后T1值降低幅度及MR推导的ECV在高级别(ISUP 3-4级)与低级别(ISUP 1-2级)肿瘤间差异有统计学意义(p < 0.001),T1差值截断值700 ms鉴别高级别与低级别肿瘤的敏感度为100%(95% CI 0.69-1.00)、特异度为82%(95% CI 0.57-0.96)。MR推导ECV与组织学ECV呈强正相关(p < 0.01,r = 0.88)。
要点
- 增强后T1值降低幅度和MR推导ECV是区分高低级别透明细胞肾细胞癌的可靠预测指标。
- T1差值截断值700 ms鉴别高级别与低级别肿瘤的敏感度为100%(95% CI 0.69-1.00)、特异度为82%(95% CI 0.57-0.96)。
- MR推导ECV与组织学ECV呈强正相关(p < 0.01,r = 0.88),T1图定量纵向弛豫时间的观察者间一致性极好。
核心结论
- 基于T1 mapping的ECV测量可能成为一种新型在体生物标志物,用于按核分级对透明细胞肾细胞癌进行分类,作为定量MR标记提供增量诊断价值。
研究设计与样本
- 单中心、经机构审查委员会批准的前瞻性研究,纳入27例经病理诊断为透明细胞肾细胞癌的患者(17例男性,中位年龄62 ± 12.4岁),于2017年1月至2018年6月间在1.5 T下行腹部MRI,采用改良Look-Locker反转恢复(MOLLI)序列,以组织病理学ISUP核分级为参考标准。
诊断标准与关键数值
- 增强后T1差值(T1diff = 平扫与肾实质期T1差值)及MR推导ECV在高级别cRCC(ISUP 3-4级)显著高于低级别cRCC(ISUP 1-2级)(p < 0.001);T1差值截断值700 ms鉴别高级别与低级别肿瘤的敏感度为100%(95% CI 0.69-1.00)、特异度为82%(95% CI 0.57-0.96);MR推导ECV与组织学ECV呈强正相关(p < 0.01,r = 0.88)。
临床应用与阅片要点
- 作者认为,T1 mapping联合ECV测量可能有助于无创评估cRCC病理,是一种安全可行的方法,并有可能优化个体化治疗方案,例如在主动监测决策中。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To assess the potential of T1 mapping-based extracellular volume fraction (ECV) for the identification of higher grade clear cell renal cell carcinoma (cRCC), based on histopathology as the reference standard.
METHODS: For this single-center, institutional review board-approved prospective study, 27 patients (17 men, median age 62 ± 12.4 years) with pathologic diagnosis of cRCC (nucleolar International Society of Urological Pathology (ISUP) grading) received abdominal MRI scans at 1.5 T using a modified Look-Locker inversion recovery (MOLLI) sequence between January 2017 and June 2018. Quantitative T1 values were measured at different time points (pre- and postcontrast agent administration) and quantification of the ECV was performed on MRI and histological sections (H&E staining).
RESULTS: Reduction in T1 value after contrast agent administration and MR-derived ECV were reliable predictors for differentiating higher from lower grade cRCC. Postcontrast T1diff values (T1diff = T1 difference between the native and nephrogenic phase) and MR-derived ECV were significantly higher for higher grade cRCC (ISUP grades 3-4) compared with lower grade cRCC (ISUP grades 1-2) (p < 0.001). A cutoff value of 700 ms could distinguish higher grade from lower grade tumors with 100% (95% CI 0.69-1.00) sensitivity and 82% (95% CI 0.57-0.96) specificity. There was a positive and strong correlation between MR-derived ECV and histological ECV (p < 0.01, r = 0.88). Interobserver agreement for quantitative longitudinal relaxation times in the T1 maps was excellent.
CONCLUSIONS: T1 mapping with ECV measurement could represent a novel in vivo biomarker for the classification of cRCC regarding their nucleolar grade, providing incremental diagnostic value as a quantitative MR marker.
KEY POINTS: • Reduction in MRI T1 relaxation times after contrast agent administration and MR-derived extracellular volume fraction are useful parameters for grading of clear cell renal cell carcinoma (cRCC). • T1 differences between the native and the nephrogenic phase are higher for higher grade cRCC compared with lower grade cRCC and MRI-derived extracellular volume fraction (ECV) and histological ECV show a strong correlation. • T1 mapping with ECV measurement may be helpful for the noninvasive assessment of cRCC pathology, being a safe and feasible method, and it has potential to optimize individualized treatment options, e.g., in the decision of active surveillance.
引用
- Adams LC, Jurmeister P, Ralla B, et al. Assessment of the extracellular volume fraction for the grading of clear cell renal cell carcinoma: first results and histopathological findings. Eur Radiol. 2019. PMID: 30887194. doi:10.1007/s00330-019-06087-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。